From October 1, 2021 to December 31, 2021, the company has repurchased 2,357,000 shares, representing 1.44% for $27.13 million. With this, the company has completed the repurchase of 2,357,000 shares, representing 1.44% for $27.13 million under the buyback announced on May 6, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.82 USD | -0.87% |
|
+5.57% | -40.38% |
01/07 | Ironwood Pharmaceuticals, Inc.(NasdaqGS:IRWD) dropped from Russell 2000 Value-Defensive Index | CI |
01/07 | Ironwood Pharmaceuticals, Inc.(NasdaqGS:IRWD) added to Russell 2000 Dynamic Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.38% | 109.36Cr | |
+24.74% | 4.8TCr | |
-0.47% | 4.24TCr | |
+43.96% | 4.15TCr | |
+25.40% | 3.16TCr | |
+17.96% | 2.86TCr | |
-4.47% | 2.8TCr | |
+50.73% | 1.46TCr | |
+42.56% | 1.41TCr | |
+1.46% | 1.26TCr |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Tranche Update on Ironwood Pharmaceuticals, Inc.'s Equity Buyback Plan announced on May 6, 2021.